Premature ovarian failure in galactosaemia: Pathophysiology and clinical management;L'insuffisance ovarienne prématurée dans la galactosémie congénitale: Physiopathologie et prise en charge

Pathologie Biologie

Volumn 51, Issue 1, 2003, Pages 47-56

  Forges, T ^a   Monnier Barbarino, P ^a  

^a Maternite Regionale Universitaire   (France)

Author keywords

Apoptosis; Galactosaemia; Hormonal replacement therapy; Premature ovarian failure

Indexed keywords

ANTIOXIDANT; BROMOCRIPTINE; ESTROGEN; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GONADOTROPIN; HORMONE; PROGESTERONE; URIDINE DERIVATIVE;

APOPTOSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIET THERAPY; DISEASE SEVERITY; ENZYME DEFICIENCY; GALACTOSEMIA; GLYCOSYLATION; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; OSTEOLYSIS; OSTEOPOROSIS; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PREGNANCY; REVIEW;

ESTROGEN REPLACEMENT THERAPY; FEMALE; GALACTOSE; GALACTOSEMIAS; HETEROZYGOTE; HUMANS; OVARIAN FAILURE, PREMATURE; PREGNANCY; UTP-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

EID: 0037299497     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00002-0     Document Type: Review

References (52)

1. Anasti JN. Premature ovarian failure: un update. Fertil Steril 1998;70: 1-15.
2. Monnier-Barbarino P, Forges T. Les bases génétiques de la défaillance ovarienne prématurée. J Gynecol Obstet Biol Reprod 2000;31: 333-42.
3. Waggoner DD, Buist NRM, Donnell G. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 1990;13:802-18.
4. Liu G, Hale GE, Hughes CL. Galactose metabolism and ovarian toxicity. Reprod Toxicol 2000;14:377-84.
5. Cooper GS, Hulka BS, Baird DD, Savitz DA, Hughes Jr CL, Weinberg CR, et al. Galactose consumption, metabolism and follicle-stimulating hormone concentrations in women of late reproductive age. Fertil Steril 1994;62:1168-75.
6. Berry GT, Nissim I, Gibson GB, Mazur AT, Lin Z, Elsas LJ, et al. Quantitative assessment of whole body galactose metabolism in galactosemic patients. Eur J Pediatr 1997;156(Suppl 1):S43-9.
7. Segal S, Berry GT. Disorders of galactose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 7th Edition. New York: McGraw-Hill; 1995. p. 967-1000.
8. Segal S. Galactosemia today: the enigma and the challenge, Komrower lecture. J Inher Metab Dis 1998;21:455-71.
9. Novelli G, Reichardt JKV. Molecular basis of disorders of human galactose metabolism: past, present, and future. Mol Genet Metab 2000;71:62-5.
10. Tyfield L, Reichardt J, Fridovich-Keil J, Croke DT, Elsas LJII, Strobl W, et al. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (Galt) gene. Hum Mutat 1999;13:417-30.
11. Elsas IILJ, Langley S, Paulk EM, Hjelm LN, Dembure PP. A molecular approach to galactosemia. Eur J Pediatr 1995;154(Suppl 2):S21-7.
12. Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 1993;152:36-43.
13. Walter JH, Collins JE, Leonard JV. Recommendations for the management of galactosemia. Arch Dis Child 1999;80:93-6.
14. Kaufman F, Kogut MD, Donnell GN, Koch R. Ovarian failure in galactosaemia. Lancet i 1979:737-8.
15. Twigg S, Wallman L, McElduff A. The resistant ovary syndrome in a patient with galactosemia: A clue to the natural history of ovarian failure. J Clin Metab Endocr 1996;81:1329-31.
16. Levy HL, Driscoll SG, Porensky RS, Wender DF. Ovarian failure in galactosemia. N Engl J Med 1984;310(50).
17. Kaufman FR, Xu YK, Ng WG, Silva PD, Lobo RA, Donnell GN. Gonadal function and ovarian galactose metabolism in classic galactosemia. (Copenh). Acta Endocrinol 1989;120:129-33.
18. Gibson JB. Gonadal function in galactosemics and in galactose-intoxicated animals. Eur J Pediatr 1995;154(Suppl 2):S14-20.
19. Kaufmann FR, Kogut MD, Donnell GN, Gœbelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-8.
20. Tyfield LA. Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype. Eur J Pediatr 2000;159(Suppl 3):S204-7.
21. Guerrero NV, Singh RH, Manatunga A, Berry GT, Steiner RD, Elsas IILJ. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 2000;137:833-41.
22. Kaufman FR, Xu YK, Ng WG, Donnell GN. Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia. J Pediatr 1988;112:754-6.
23. Lai K, Langley SD, Singh R, Dembure PP, Hjelm LN, Elsas LJ. A prevalent mutation for galactosæmia among black Americans. J Pediatr 1996;128:89-95.
24. Briones P, Giros M, Martinez V. Second spontaneous pregnancy in a galactosæmic woman homozygous for the Q188R mutation. J Inher Metab Dis 2001;24:79-80.
25. Kimonis V. A further pregnancy in a woman with classic galactosemia who delivered triplets followed by premature ovarian failure. J Inher Metab Dis 2000;23(Suppl 1):156.
26. Cramer DW, Harlow BL, Barbieri RL, Ng WG. Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history. Fertil Steril 1989;51:609-15.
27. Herrinton L, Lemaitre RN, Beresford SAA, Stanford JL, Wolfla DM, Feng Z, et al. Lactose metabolism and time to pregnancy. Fertil Steril 1996;66:384-8.
28. Sayle AE, Cooper GS, Savitz DA. Menstrual and reproductive history of mothers of galactosemic children. Fertil Steril 1996;65:534-8.
29. Kaufman FR, Devgan S, Donnell GN. Results of a survey of carrier women for the galactosemia gene. Fertil Steril 1993;60:727-8.
30. Hagenfelt K, von Döbeln U, Hagenfelt L. Gonadal failure in young women and galactose-1-phosphate uridyl transferase activity. Fertil Steril 1989;51:177-8.
31. Xu YK, Ng WG, Kaufman FR, Lobo RA, Donnell GN. Galactose metabolism in human ovarian tissue. Pediatr Res 1989;25:151-5.
32. Heidenreich RA, Mallee J, Rogers S, Segal S. Developmental and tissue-specific modulation of rat galactose-1-phosphate uridyltranferase steady state messenger RNA and specific activity levels. Pediatr Res 1994;34:416-9.
33. Meyer WR, Doyle MB, Grifo JA, Lipetz KJ, Oates PJ, DeCherney AH, et al. Aldose reductase inibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat. Am J Obstet Gynecol 1992;167:1837-43.
34. Jakobs C, Kleyer WG, Bakker HD, Van Gennip AH, Przyrembel H, Niermeyer ME Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in the amniotic fluid of foetuses affected with galactosemia. Prenat Diagn 1988;8:641-5.
35. Steinmann B, Gitzelmann R, Zachmann M. Galactosemia: Hypergonadotropic hypogonadism found already in prepubertal girls but only in adult males. Eur J Pediatr 1981;135:337.
36. Ng WG, Xu YK, Kaufman FR, Donnell GN. Deficit of uridine diphosphate galactose in galactosemia. J Inher Metab Dis 1989;12:257-66.
37. Prestoz LLC, Couto AS, Shin YS, Petry KG. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur J Pediatr 1997;156:116-20.
38. Keene JL, Nishimori K, Galway AB, Matzuk MM, Hsueh AJW, Boime I. Recombiant deglycosylated human FSH is an antagonist of human FSH action in cultured rat granulosa cells. Endocr J 1994;2: 175-80.
39. Petry KG, Reichardt JKV. The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry. Trends Genet 1998;14:98-102.
40. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407: 770-6.
41. Reynaud K, Driancourt MA. Oocyte attrition. Mol Cell Endocrinol 2000;163:101-8.
42. Murata M, Ohta N, Sakurai S, Alam S, Tsai JY, Kador PF, et al. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). Chem Biol Interact 2001;130-132:617-25.
43. Sato S, Murata M, Ohta N, Tsai JY, Kador PF. Galactose induces apoptosis of dog retinal capillary pericytes, but not of endothelial cells. Investigative Ophtalmology & Visual Science 1999;40:S370.
44. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002; 51:1172-9.
45. Odièvre M, Brivet M, Rivière MF, Labrune P. Partial effect of bromocriptine on lactose and galactose synthesis in a pregnant woman heterozygous for galactosemia. J Inherit Metab Dis 2001;24:507-8.
46. Odièvre M. Le traitement de la galactosémie: de nouvelles stratégies? Arch Pediatr 2002;9:563-5.
47. Oktay K, Buyuk E. The potential of ovarian tissue transplant to preserve fertility. Expert Opin Biol Ther 2002;2:361-70.
48. Kaufmann FR, Loro ML, Azen C, Wenz E, Gilsanz V. Effect of hypogonadism and deficient calcium intake on bone density in patients with galactosemia. J Pediatr 1993;123:365-70.
49. Renner C, Razeghi S, Uberall MA, Licht P, Wildt L, Dörr HG, et al. Hormone replacement therapy in galactosaemic twins with ovarian failure and severe osteoporosis. J Inher Metab Dis 1999;22:194-5.
50. Rubio-Gozalbo ME, Hamming S, Van Kronenburgh MJ, Bakker JA, Vermeer C, Forget PP. Bone mineral density in patients with classic galactosaemia. Arch Dis Child 2002;87:57-60.
51. Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:811-6.
52. Barbarino-Monnier P. Du constat pathologique à l'obtention de l'ovulation. Le cas des déficiences ovariennes. Gynecol Obstet Fertil 2001;29:39-48.